USPTO Examiner BABSON NICOLE PLOURDE - Art Unit 1619

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18811158METHODS FOR FIXING HAIR AND SKINAugust 2024November 2024Allow310NoNo
18456072WHITE PIGMENT FOR COSMETICS, AND COSMETICAugust 2023November 2024Abandon1510NoNo
18222641PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGESJuly 2023January 2025Abandon1811NoNo
18257531RESIN BEADS, METHOD FOR PRODUCING RESIN BEADS, AND PRODUCT USING RESIN BEADSJune 2023September 2024Allow1511YesNo
18318647FORMULATIONS AND METHODS FOR TREATING HAIRMay 2023December 2024Allow1931YesNo
18130478ANTI-AGING COMPOSITION BASED ON MIXED ESTER OF STILBENIC EXTRACTApril 2023September 2023Allow511NoNo
18185696COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINSMarch 2023September 2024Allow1811NoNo
18113449CONFORMAL COATING OF CELLS FOR IMMUNOISOLATIONFebruary 2023March 2025Allow2410YesNo
18005072NOVEL SPHINGOLIPID, AND DERMATOLOGIC COMPOSITION COMPRISING SAME FOR EXTERNAL APPLICATIONJanuary 2023June 2025Allow2900NoNo
17998069UROGENITAL CLEANSING COMPOSITIONNovember 2022April 2023Allow610NoNo
18053148HAIR TREATMENT FORMULATIONS AND USES THEREOFNovember 2022December 2024Allow2510YesNo
17978460COMPOSITIONS COMPRISING MOLECULARLY SEPARATED CANNABINOIDS AND TERPENE BLENDS AND METHODS OF PRODUCINGNovember 2022January 2024Abandon1521YesNo
17960263COSMETIC COMPOSITION FOR A MATTE FOUNDATIONOctober 2022November 2024Allow2511NoNo
17958074COATED POWDERS HAVING HIGH PHOTOSTABILITYSeptember 2022October 2024Abandon2421NoNo
17901710Personal Care CompositionsSeptember 2022September 2024Allow2421NoNo
17818653COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROSTAugust 2022December 2023Abandon1710NoNo
17869210METHOD FOR LONG-TERM TREATMENT OF ROSACEAJuly 2022August 2024Abandon2520NoNo
17787524GEL NAIL STICKER AND METHOD FOR MANUFACTURING THE SAMEJune 2022September 2023Abandon1501NoNo
17836882DIESTER COSMETIC FORMULATIONS AND USES THEREOFJune 2022September 2024Allow2821NoNo
17832018SKINCARE REJUVENATION COMPOSITION AND METHOD OF MANUFACTUREJune 2022November 2023Abandon1711NoNo
17663788HAIR TREATMENT FORMULATIONS AND USES THEREOFMay 2022August 2023Allow1520YesNo
17717054Insect Repellent Pet CollarApril 2022November 2024Allow3110NoNo
17717052Wearable Insect Repellent Device and MethodApril 2022July 2023Allow1510NoNo
17704431COMPOSITION FOR ENHANCING KERATIN FIBERSMarch 2022March 2024Allow2341NoNo
17698075COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINSMarch 2022February 2023Allow1121YesNo
17640056NEW PLATINUM IV COMPLEXES WITH SUBSTANTIALLY INCREASED ANTITUMOR EFFICACYMarch 2022April 2025Allow3810NoNo
17676736Device for Use in the Removal of Nail Polish from a Person's NailsFebruary 2022January 2024Allow2321NoNo
17627475CHEWING GUM COMPOSITIONS FOR THE TREATMENT OF MENOPAUSAL SYMPTOMSJanuary 2022June 2025Abandon4111NoNo
17563750HAIR SHINE COMPOSITIONSDecember 2021June 2024Allow2911YesNo
17558073BIOLOGIC FILLER FOR RESTORING AND REGENERATING TISSUEDecember 2021December 2024Allow3611NoNo
17555330WATER-BASED NAIL POLISHDecember 2021April 2024Abandon2811NoNo
17543282OIL-IN-WATER EMULSION COSMETICDecember 2021April 2023Allow1700NoNo
17539840HAIR TREATMENT FORMULATIONS AND USES THEREOFDecember 2021September 2022Allow912YesNo
17528442CONFORMAL COATING OF CELLS FOR IMMUNOISOLATIONNovember 2021November 2022Allow1220NoNo
17525252Formulation and Use Thereof in the Treatment of Keratosis PilarisNovember 2021August 2023Abandon2101NoNo
17594634DERIVATIVES OF GYLCERO-MANNO-HEPTOSE ADP FOR USE IN MODULATING IMMUNE RESPONSEOctober 2021March 2025Abandon4101NoNo
17451590Decolorization of Dyed Keratinic FibersOctober 2021December 2023Abandon2620NoNo
17594468MANGANESE COMPOSITION FOR ENHANCING IMMUNITYOctober 2021February 2025Allow4011NoNo
17496502EMOLLIENT AND CLEANSING AGENTOctober 2021March 2024Abandon2921NoNo
17494227PEELABLE MAKEUP REMOVING COMPOSITIONSOctober 2021May 2024Allow3221NoNo
17441884COSMETIC COMPOSITION FOR HAIRSeptember 2021March 2025Abandon4211NoNo
17411543DILUTE LONG-WEARING COSMETIC COMPOSITION COMPRISING MIXED SENSORY MODIFIERSAugust 2021August 2024Abandon3531NoNo
17405280Compositions for Treatment of Nails and skinAugust 2021March 2023Abandon1910NoNo
17405566METHODS OF CURING DICARBONYL SUBSTITUTED-1-ALKENESAugust 2021June 2023Abandon2101NoNo
17403232VISCOELASTIC COMPOSITIONAugust 2021May 2025Allow4511YesNo
17428797HEMOSTATIC BIOPSY TRACT ARTICLEAugust 2021May 2025Allow4520NoNo
17393929HAIR-TREATMENT COMPOSITION AND METHODS OF USEAugust 2021May 2024Allow3330NoNo
17389758WATER-SOLUBLE FIBROUS POUCH CONTAINING PRILLS FOR HAIR CAREJuly 2021January 2024Allow2921NoNo
17380390DIESTER COSMETIC FORMULATIONS AND USES THEREOFJuly 2021March 2022Allow811YesNo
17379405HAIR LIGHTENING COMPOSITIONS AND METHODS OF USEJuly 2021April 2025Abandon4531YesYes
17363904NAIL-DECORATING AND STYLING KITJune 2021April 2022Allow1011YesNo
17359724MIXED SUGAR COMPOSITIONSJune 2021August 2023Abandon2511NoNo
17358740ARTIFICIAL NAIL TIP AND CURING COMPOSITION SET AND APPLYING METHOD THEREOFJune 2021July 2023Allow2411NoNo
17413013SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR CHRONOTROPIC ADMINISTRATION OF SARTANSJune 2021March 2025Abandon4511NoNo
17341735NAIL PRODUCTS, METHODS OF USE AND KITSJune 2021September 2023Abandon2811NoNo
17340750SPRAY TYPE COSMETIC COMPOSITION HAVING MAKEUP-MAINTAINING ABILITY AND SPRAYING POWERJune 2021July 2023Allow2511YesNo
17335674Method of Improving Penetration of a Vitamin B3 Compound into SkinJune 2021December 2022Allow1910NoNo
17297283A METHOD FOR PRODUCING ENTACAPONE TABLETSMay 2021November 2024Abandon4200NoNo
17291326SMALL-SCALE ROBOTS FOR BIOFILM ERADICATIONMay 2021June 2025Allow5011NoNo
17284607COMPOSITIONS AND METHODS FOR TRANSFECTING CELLSApril 2021May 2025Abandon5011NoNo
17226575WATER-BASED COSMETICApril 2021July 2024Abandon3940YesNo
17284179METHOD FOR TREATING KERATIN MATERIALS USING AN ACRYLIC ANHYDRIDE POLYMER IN OILY DISPERSION AND AN AMINE COMPOUNDApril 2021March 2025Abandon4821NoNo
17217742TWO PHASE WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVERMarch 2021April 2025Allow4841YesYes
17277952AN IMPLANTABLE DEVICE AND A METHOD FOR IMPLANTING SAID DEVICE IN A SUBJECTMarch 2021June 2025Allow5121NoNo
17278171COMPOSITION CONTAINING WATER-SOLUBLE NON-IONIC POLYURETHANE DISPERSION, AND PREPARATION METHOD THEREFORMarch 2021January 2025Allow4611NoNo
17205188COMPOSITION COMPRISING KAKKALIDEMarch 2021March 2023Abandon2401NoNo
17206050COMPOSITIONS AND METHODS FOR LABELING AND MODULATION OF CELLS IN VITRO AND IN VIVOMarch 2021November 2024Allow4411NoNo
17203118HAIR TREATMENT PASTEMarch 2021May 2023Allow2611NoNo
17195715Personal Care CompositionsMarch 2021June 2024Abandon4041YesNo
17271148ORAL FORMULATIONS OF PHENYLALANINE AND CANNABINOIDSFebruary 2021July 2024Abandon4101NoNo
17182261Lotion Pellet and Method of ManufactureFebruary 2021July 2023Abandon2911NoNo
17166337COMPOSITION AND PROCESS FOR TREATING HAIRFebruary 2021September 2023Allow3221NoNo
17261074ANTIMICROBIAL COMPOSITIONS AND METHODSJanuary 2021April 2024Abandon3901NoNo
17260373PESTICIDAL MIXTURES COMPRISING INDAZOLESJanuary 2021March 2024Allow3801NoNo
17258786CROSSLINKED ORGANOSILICON RESIN, A METHOD FOR PRODUCING SAME, AND A COSMETICJanuary 2021October 2023Allow3311NoNo
17251052ENZYMATIC MOLECULE MIMICKING ANTI-OXIDANT ACTIVITYDecember 2020October 2023Allow3431YesNo
16973141COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATEDecember 2020January 2023Allow2611NoNo
16952423COSMETIC COMPOSITION WITH A METALLIC EFFECTNovember 2020March 2023Abandon2821NoNo
17056592PRESERVATION COMPOSITIONSNovember 2020September 2023Allow3321YesNo
17052897PRISTINE GRAPHENE AND COMPOSITIONS WITH NATURAL PRESSURE SENSITIVE ADHESIVE (PSA) METHOD FOR OVER SKIN APPLICATIONSNovember 2020February 2023Abandon2701NoNo
17250011Cosmetic CompositionsOctober 2020June 2024Abandon4341YesNo
17076386COMPOSITION AND METHOD EFFECTIVE FOR INDUCTION OF REMISSION OF CROHN'S DISEASEOctober 2020October 2024Allow4821NoNo
17047751COSMETIC COMPOSITIONSOctober 2020July 2023Allow3311NoNo
17046543GARDENIA RED PIGMENT STABLY ADSORBED ON SURFACE OF SILICA, AND COSMETIC COMPOSITION CONTAINING SAMEOctober 2020January 2024Abandon4040NoNo
17044049OPAQUE COMPOSITION COMPRISING ETHYLENE GLYCOL DISTEARATESeptember 2020August 2024Allow4761YesNo
17043166WHITE PIGMENT FOR COSMETICS, AND COSMETICSeptember 2020November 2023Abandon3730NoNo
16978917AGENT FOR FORMING FILM ON SKINSeptember 2020August 2022Allow2410YesNo
17013031SKINCARE REJUVENATION COMPOSITION AND METHOD OF MANUFACTURESeptember 2020February 2022Allow1731NoNo
16993405CONDUCTIVE POLYMER GRAPHENE OXIDE COMPOSITE MATERIALSAugust 2020November 2022Allow2711YesNo
16990236Cardiovascular ProsthesesAugust 2020February 2024Abandon4210NoNo
16968727SOLID POWDER COSMETICAugust 2020January 2024Abandon4140NoNo
16944928MAKEUP SETTING MOUSSEJuly 2020May 2024Allow4531NoNo
16965772POWDER-CONTAINING COMPOSITION, POWDER FOR AQUEOUS SOLVENT, AND PRODUCTION METHOD OF POWDER FOR AQUEOUS SOLVENTJuly 2020August 2024Abandon4911NoNo
16965528POWDER-CONTAINING COMPOSITION, POWDER FOR AQUEOUS SOLVENT, AND PRODUCTION METHOD OF POWDER FOR AQUEOUS SOLVENTJuly 2020August 2022Abandon2401NoNo
16911969NAIL PRODUCTS, METHODS OF USE AND KITSJune 2020March 2021Allow811YesNo
16908099COMPOSITION FOR ENHANCING SKIN ELASTICITY OR IMPROVING SKIN WRINKLES COMPRISING HEPTAHYDROXYFLAVAN AS AN EFFECTIVE INGREDIENTJune 2020September 2022Allow2711NoNo
16955638PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATIONJune 2020September 2023Abandon3901NoNo
16772287PROCESS FOR TREATING HAIRJune 2020October 2024Abandon5251NoNo
16772415NEW ALKYL POLYRHAMNOSIDES, PROCESS FOR THE PREPARATION THEREOF, AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING SAMEJune 2020May 2022Allow2310NoNo
16772364NEW POLYOL POLYRHAMNOSIDES, PROCESS FOR THE PREPARATION THEREOF, AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING SAMEJune 2020May 2022Allow2310NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BABSON, NICOLE PLOURDE.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
38
Examiner Affirmed
30
(78.9%)
Examiner Reversed
8
(21.1%)
Reversal Percentile
33.2%
Lower than average

What This Means

With a 21.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
75
Allowed After Appeal Filing
11
(14.7%)
Not Allowed After Appeal Filing
64
(85.3%)
Filing Benefit Percentile
15.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 14.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BABSON, NICOLE PLOURDE - Prosecution Strategy Guide

Executive Summary

Examiner BABSON, NICOLE PLOURDE works in Art Unit 1619 and has examined 511 patent applications in our dataset. With an allowance rate of 44.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner BABSON, NICOLE PLOURDE's allowance rate of 44.2% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BABSON, NICOLE PLOURDE receive 2.91 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BABSON, NICOLE PLOURDE is 35 months. This places the examiner in the 19% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +32.0% benefit to allowance rate for applications examined by BABSON, NICOLE PLOURDE. This interview benefit is in the 83% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.0% of applications are subsequently allowed. This success rate is in the 5% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 21.2% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 42.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 37% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 39.7% of appeals filed. This is in the 4% percentile among all examiners. Of these withdrawals, 48.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 54.8% are granted (fully or in part). This grant rate is in the 69% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.2% of allowed cases (in the 50% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 1% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.